What is NDC 83468-070?

83468-070 is the product NDC for Cardamyst (etripamil), Etripamil 70 mg/.2mL spray, listed with the FDA by Milestone Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Milestone Pharmaceuticals USA, Inc., NDC labeler code 83468. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cardamyst?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cardamyst NDC 83468-070 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)83468-070Labeler and product segments. Claims need a package NDC.

Product NDC at billing width83468-0070Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
83468-070-03	83468007003	2 CONTAINER in 1 CARTON (83468-070-03) / 2 VIAL, SINGLE-DOSE in 1 CONTAINER (83468-070-02) / .2 mL in 1 VIAL, SINGLE-DOSE (83468-070-01)Marketed from Jan 5, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cardamyst
Generic name (nonproprietary): etripamil
Active ingredients: Etripamil — 70 mg/.2mL
Dosage form: Spray
Route: Nasal
Labeler: Milestone Pharmaceuticals USA, Inc.NDC labeler code 83468
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 218571
Marketing start: Jan 5, 2026
Listing expires: Dec 31, 2026
Identifiers: Product ID 83468-070_6a4934f2-7bae-4f50-9ccc-619d7efe31e1SPL ID 6a4934f2-7bae-4f50-9ccc-619d7efe31e1SPL set ID a92170b9-4f93-4b83-b2cd-cb85c52821cdRxCUI 2730307, 2730313UNII S82A18Y42P

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Nasal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N483468007003 followed by a unit qualifier and the quantity

Package 83468-0070-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 8, 2025.

Indications (excerpt from the label)

CARDAMYST is indicated for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. CARDAMYST is a calcium channel blocker indicated for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 83468-070

What is NDC 83468-070?: 83468-070 is the product NDC for Cardamyst (etripamil), Etripamil 70 mg/.2mL spray, listed with the FDA by Milestone Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Cardamyst (Etripamil).
What is the active ingredient?: Etripamil.
Who is the labeler?: Milestone Pharmaceuticals USA, Inc., NDC labeler code 83468. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cardamyst?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Cardamyst (Etripamil) NDC 83468-070